• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of annrheumdAnnals of the Rheumatic DiseasesVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Ann Rheum Dis. Mar 2005; 64(Suppl 2): ii26–ii29.
PMCID: PMC1766860

Immunopathology of psoriasis and psoriatic arthritis


Psoriatic arthritis (PsA) is characterised by several unique clinical features that differentiate it from rheumatoid arthritis (RA). Attempts to identify immunopathological mechanisms, some shared with psoriasis, that underlie these differences from RA have been most challenging. Recent research studies, however, highlight novel findings in PsA at the molecular, cellular, and tissue levels that form the basis for a new understanding of this relatively common form of inflammatory arthritis. In particular, the availability of new, biological antitumour necrosis factor α therapies have allowed further insight into the immunopathology of psoriasis and PsA. This brief review focuses on immunohistological studies in psoriatic skin, PsA synovium, and bone to demonstrate how these data advance our knowledge of disease pathogenesis.

Full Text

The Full Text of this article is available as a PDF (109K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Veale D, Yanni G, Rogers S, Barnes L, Bresnihan B, Fitzgerald O. Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum. 1993 Jul;36(7):893–900. [PubMed]
  • Veale DJ, Barnes L, Rogers S, FitzGerald O. Immunohistochemical markers for arthritis in psoriasis. Ann Rheum Dis. 1994 Jul;53(7):450–454. [PMC free article] [PubMed]
  • Laloux L, Voisin MC, Allain J, Martin N, Kerboull L, Chevalier X, Claudepierre P. Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis. Ann Rheum Dis. 2001 Apr;60(4):316–321. [PMC free article] [PubMed]
  • Costello P, Bresnihan B, O'Farrelly C, FitzGerald O. Predominance of CD8+ T lymphocytes in psoriatic arthritis. J Rheumatol. 1999 May;26(5):1117–1124. [PubMed]
  • Paukkonen K, Naukkarinen A, Horsmanheimo M. The development of manifest psoriatic lesions is linked with the invasion of CD8 + T cells and CD11c + macrophages into the epidermis. Arch Dermatol Res. 1992;284(7):375–379. [PubMed]
  • Gottlieb SL, Gilleaudeau P, Johnson R, Estes L, Woodworth TG, Gottlieb AB, Krueger JG. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med. 1995 May;1(5):442–447. [PubMed]
  • Costello PJ, Winchester RJ, Curran SA, Peterson KS, Kane DJ, Bresnihan B, FitzGerald OM. Psoriatic arthritis joint fluids are characterized by CD8 and CD4 T cell clonal expansions appear antigen driven. J Immunol. 2001 Feb 15;166(4):2878–2886. [PubMed]
  • Gladman DD, Anhorn KA, Schachter RK, Mervart H. HLA antigens in psoriatic arthritis. J Rheumatol. 1986 Jun;13(3):586–592. [PubMed]
  • Winchester R, Brancato L, Itescu S, Skovron ML, Solomon G. Implications from the occurrence of Reiter's syndrome and related disorders in association with advanced HIV infection. Scand J Rheumatol Suppl. 1988;74:89–93. [PubMed]
  • Chang JC, Smith LR, Froning KJ, Schwabe BJ, Laxer JA, Caralli LL, Kurland HH, Karasek MA, Wilkinson DI, Carlo DJ, et al. CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes. Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9282–9286. [PMC free article] [PubMed]
  • Tassiulas I, Duncan SR, Centola M, Theofilopoulos AN, Boumpas DT. Clonal characteristics of T cell infiltrates in skin and synovium of patients with psoriatic arthritis. Hum Immunol. 1999 Jun;60(6):479–491. [PubMed]
  • Curran Shane A, FitzGerald Oliver M, Costello Patrick J, Selby Jeanette M, Kane David J, Bresnihan Barry, Winchester Robert. Nucleotide sequencing of psoriatic arthritis tissue before and during methotrexate administration reveals a complex inflammatory T cell infiltrate with very few clones exhibiting features that suggest they drive the inflammatory process by recognizing autoantigens. J Immunol. 2004 Feb 1;172(3):1935–1944. [PubMed]
  • Ridge JP, Di Rosa F, Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature. 1998 Jun 4;393(6684):474–478. [PubMed]
  • Nickoloff BJ, Bonish B, Huang BB, Porcelli SA. Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system. J Dermatol Sci. 2000 Dec;24(3):212–225. [PubMed]
  • Veale D, Rogers S, Fitzgerald O. Immunolocalization of adhesion molecules in psoriatic arthritis, psoriatic and normal skin. Br J Dermatol. 1995 Jan;132(1):32–38. [PubMed]
  • Pitzalis C, Cauli A, Pipitone N, Smith C, Barker J, Marchesoni A, Yanni G, Panayi GS. Cutaneous lymphocyte antigen-positive T lymphocytes preferentially migrate to the skin but not to the joint in psoriatic arthritis. Arthritis Rheum. 1996 Jan;39(1):137–145. [PubMed]
  • Kane David, Roth Johannes, Frosch Michael, Vogl Thomas, Bresnihan Barry, FitzGerald Oliver. Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis. Arthritis Rheum. 2003 Jun;48(6):1676–1685. [PubMed]
  • Braverman IM, Yen A. Microcirculation in psoriatic skin. J Invest Dermatol. 1974 May;62(5):493–502. [PubMed]
  • Braverman IM, Yen A. Ultrastructure of the capillary loops in the dermal papillae of psoriasis. J Invest Dermatol. 1977 Jan;68(1):53–60. [PubMed]
  • Zaric D, Worm AM, Stahl D, Clemmensen OJ. Capillary microscopy of the nailfold in psoriatic and rheumatoid arthritis. Scand J Rheumatol. 1981;10(3):249–252. [PubMed]
  • Bhushan M, Moore T, Herrick AL, Griffiths CE. Nailfold video capillaroscopy in psoriasis. Br J Dermatol. 2000 Jun;142(6):1171–1176. [PubMed]
  • Reece RJ, Canete JD, Parsons WJ, Emery P, Veale DJ. Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis. Arthritis Rheum. 1999 Jul;42(7):1481–1484. [PubMed]
  • Fearon Ursula, Griosios Konstantina, Fraser Alexander, Reece Richard, Emery Paul, Jones Pamela F, Veale Douglas J. Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol. 2003 Feb;30(2):260–268. [PubMed]
  • Creamer D, Sullivan D, Bicknell R, Barker J. Angiogenesis in psoriasis. Angiogenesis. 2002;5(4):231–236. [PubMed]
  • Creamer D, Jaggar R, Allen M, Bicknell R, Barker J. Overexpression of the angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase in psoriatic epidermis. Br J Dermatol. 1997 Dec;137(6):851–855. [PubMed]
  • Fearon U, Reece R, Smith J, Emery P, Veale DJ. Synovial cytokine and growth factor regulation of MMPs/TIMPs: implications for erosions and angiogenesis in early rheumatoid and psoriatic arthritis patients. Ann N Y Acad Sci. 1999 Jun 30;878:619–621. [PubMed]
  • Kuroda K, Sapadin A, Shoji T, Fleischmajer R, Lebwohl M. Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis. J Invest Dermatol. 2001 May;116(5):713–720. [PubMed]
  • Eedy DJ, Johnston CF, Shaw C, Buchanan KD. Neuropeptides in psoriasis: an immunocytochemical and radioimmunoassay study. J Invest Dermatol. 1991 Apr;96(4):434–438. [PubMed]
  • Veale D, Farrell M, Fitzgerald O. Mechanism of joint sparing in a patient with unilateral psoriatic arthritis and a longstanding hemiplegia. Br J Rheumatol. 1993 May;32(5):413–416. [PubMed]
  • Mulherin D, Bresnihan B, FitzGerald O. Digital denervation associated with absence of nail and distal interphalangeal joint involvement in psoriatic arthritis. J Rheumatol. 1995 Jun;22(6):1211–1212. [PubMed]
  • Fearon U, Veale DJ. Pathogenesis of psoriatic arthritis. Clin Exp Dermatol. 2001 Jun;26(4):333–337. [PubMed]
  • Fraser Alexander, Fearon Ursula, Billinghurst R Clark, Ionescu Mirela, Reece Richard, Barwick Thomas, Emery Paul, Poole A Robin, Veale Douglas J. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation. Arthritis Rheum. 2003 Nov;48(11):3085–3095. [PubMed]
  • Ritchlin C, Haas-Smith SA, Hicks D, Cappuccio J, Osterland CK, Looney RJ. Patterns of cytokine production in psoriatic synovium. J Rheumatol. 1998 Aug;25(8):1544–1552. [PubMed]
  • Valdimarsson H, Baker BS, Jónsdóttir I, Powles A, Fry L. Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today. 1995 Mar;16(3):145–149. [PubMed]
  • Kupper Thomas S. Immunologic targets in psoriasis. N Engl J Med. 2003 Nov 20;349(21):1987–1990. [PubMed]
  • Danning CL, Illei GG, Hitchon C, Greer MR, Boumpas DT, McInnes IB. Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis. Arthritis Rheum. 2000 Jun;43(6):1244–1256. [PubMed]
  • Kane David, FitzGerald Oliver. Tumor necrosis factor-alpha in psoriasis and psoriatic arthritis: a clinical, genetic, and histopathologic perspective. Curr Rheumatol Rep. 2004 Aug;6(4):292–298. [PubMed]
  • Nair RP, Stuart P, Henseler T, Jenisch S, Chia NV, Westphal E, Schork NJ, Kim J, Lim HW, Christophers E, et al. Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet. 2000 Jun;66(6):1833–1844. [PMC free article] [PubMed]
  • Asumalahti K, Laitinen T, Itkonen-Vatjus R, Lokki ML, Suomela S, Snellman E, Saarialho-Kere U, Kere J. A candidate gene for psoriasis near HLA-C, HCR (Pg8), is highly polymorphic with a disease-associated susceptibility allele. Hum Mol Genet. 2000 Jun 12;9(10):1533–1542. [PubMed]
  • Gonzalez S, Martinez-Borra J, Del Río JS, Santos-Juanes J, Lopez-Vazquez A, Blanco-Gelaz M, López-Larrea C. The OTF3 gene polymorphism confers susceptibility to psoriasis independent of the association of HLA-Cw*0602. J Invest Dermatol. 2000 Nov;115(5):824–828. [PubMed]
  • Balding Joanna, Kane David, Livingstone Wendy, Mynett-Johnson Lesley, Bresnihan Barry, Smith Owen, FitzGerald Oliver. Cytokine gene polymorphisms: association with psoriatic arthritis susceptibility and severity. Arthritis Rheum. 2003 May;48(5):1408–1413. [PubMed]
  • Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet. 2000 Jul 29;356(9227):385–390. [PubMed]
  • Mease Philip J. Current treatment of psoriatic arthritis. Rheum Dis Clin North Am. 2003 Aug;29(3):495–511. [PubMed]
  • Leonardi Craig L, Powers Jerold L, Matheson Robert T, Goffe Bernard S, Zitnik Ralph, Wang Andrea, Gottlieb Alice B. Etanercept as monotherapy in patients with psoriasis. N Engl J Med. 2003 Nov 20;349(21):2014–2022. [PubMed]
  • Antoni Christian, Dechant Claudia, Hanns-Martin Lorenz PD, Wendler Joerg, Ogilvie Alexandra, Lueftl Mathias, Kalden-Nemeth Dolores, Kalden Joachim R, Manger Bernhard. Open-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation. Arthritis Rheum. 2002 Oct 15;47(5):506–512. [PubMed]
  • Chaudhari U, Romano P, Mulcahy LD, Dooley LT, Baker DG, Gottlieb AB. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial. Lancet. 2001 Jun 9;357(9271):1842–1847. [PubMed]
  • Gottlieb Alice B, Matheson Robert T, Lowe Nicholas, Krueger Gerald G, Kang Sewon, Goffe Bernard S, Gaspari Anthony A, Ling Mark, Weinstein Gerald D, Nayak Anjuli, et al. A randomized trial of etanercept as monotherapy for psoriasis. Arch Dermatol. 2003 Dec;139(12):1627–1632. [PubMed]
  • Teitelbaum SL. Bone resorption by osteoclasts. Science. 2000 Sep 1;289(5484):1504–1508. [PubMed]
  • Massey HM, Flanagan AM. Human osteoclasts derive from CD14-positive monocytes. Br J Haematol. 1999 Jul;106(1):167–170. [PubMed]
  • Gravallese EM. Bone destruction in arthritis. Ann Rheum Dis. 2002 Nov;61 (Suppl 2):ii84–ii86. [PMC free article] [PubMed]
  • Boyle William J, Simonet W Scott, Lacey David L. Osteoclast differentiation and activation. Nature. 2003 May 15;423(6937):337–342. [PubMed]
  • Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, Goldring SR. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum. 2000 Feb;43(2):250–258. [PubMed]
  • Bengtsson Asa K, Ryan Elizabeth J. Immune function of the decoy receptor osteoprotegerin. Crit Rev Immunol. 2002;22(3):201–215. [PubMed]
  • Ritchlin Christopher T, Haas-Smith Sally A, Li Ping, Hicks David G, Schwarz Edward M. Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest. 2003 Mar;111(6):821–831. [PMC free article] [PubMed]
  • Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest. 2000 Dec;106(12):1481–1488. [PMC free article] [PubMed]
  • Peng Hairong, Wright Vonda, Usas Arvydas, Gearhart Brian, Shen Hsain-Chung, Cummins James, Huard Johnny. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest. 2002 Sep;110(6):751–759. [PMC free article] [PubMed]

Figures and Tables

Figure 1
 Immunohistochemical staining of tumour necrosis factor α protein in a section of psoriatic synovial membrane.

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Group


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...